Abstract

BackgroundThis study aimed to reveal the association of diabetes mellitus and dialysis-dependent renal failure with the lesion severity and chronic total occlusion (CTO) in patients undergoing femoropopliteal endovascular therapy for intermittent claudication.MethodsThis multicenter retrospective study analyzed the data of 2056 consecutive patients with moderate to severe intermittent claudication, who underwent endovascular therapy for de novo lesions in the superficial femoral artery to the proximal popliteal artery between 2010 and 2018 at five cardiovascular centers in Japan. The association of the clinical characteristics with severity of the lesions, as assessed by the Trans-Atlantic Inter-Society Consensus (TASC) II classification, was investigated using the ordinal logistic regression model. Their association with CTO, lesion length, and severity of calcifications was additionally analyzed using the binomial logistic regression model.ResultsThe prevalence of diabetes mellitus and dialysis-dependent renal failure was 54.7% and 21.4%, respectively; 12.5% of the patients had lesions corresponding to TASC II class D, and 39.3% of the patients had CTO. Current smoking and severe claudication were associated with more severe lesions assessed according to the TASC II classification; diabetes mellitus and dialysis dependence were inversely associated with disease severity. The adjusted odds ratios of diabetes mellitus and dialysis dependence were 0.82 (95% confidence interval 0.70–0.97; p = 0.018) and 0.76 (0.62–0.94; p = 0.009), respectively. Diabetes mellitus and dialysis dependence were also inversely associated with CTO (both p < 0.05). Furthermore, diabetes mellitus was inversely associated with a long lesion (p < 0.05). Diabetes mellitus and dialysis dependence were positively associated with severe calcification (both p < 0.05).ConclusionsDiabetes mellitus and dialysis-dependent renal failure were inversely associated with the lesion severity, as assessed by the TASC II classification, and CTO in patients undergoing femoropopliteal endovascular therapy for intermittent claudication.

Highlights

  • This study aimed to reveal the association of diabetes mellitus and dialysis-dependent renal failure with the lesion severity and chronic total occlusion (CTO) in patients undergoing femoropopliteal endovascular therapy for intermittent claudication

  • Adjusted odds ratios were derived from the multivariate model in which all the variables listed in the table were entered as the explanatory variables were associated with more severe disease as assessed by Trans-Atlantic Inter-Society Consensus (TASC) II classification, whereas diabetes mellitus and dialysis dependence were inversely associated with disease severity

  • Diabetes mellitus and dialysis dependence were inversely associated with CTO (Fig. 1a)

Read more

Summary

Introduction

This study aimed to reveal the association of diabetes mellitus and dialysis-dependent renal failure with the lesion severity and chronic total occlusion (CTO) in patients undergoing femoropopliteal endovascular therapy for intermittent claudication. The presence of CTO is a strong predictor of poor clinical outcomes among those undergoing femoropopliteal endovascular therapy for peripheral artery disease (PAD) [6, 7]. No clinical studies have examined which comorbidities are associated with complex lesions, especially CTO, in PAD patients. The aim of the current study was to determine the association of diabetes mellitus and dialysis-dependent renal failure with the lesion severity and CTO in patients undergoing femoropopliteal endovascular therapy for intermittent claudication Diabetes mellitus and renal failure are associated with more distally-located (i.e., especially infra-popliteal) arterial disease and more severe calcification [8], but it remains unknown whether the comorbidities are associated with CTO and lesion severity in femoropopliteal segments.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call